Illumina's Q3 Revenues Jump 50 Percent on Strength of HiSeq
October 27, 2010
Illumina's Q3 Revenues Jump 50 Percent on Strength of HiSeq
The firm said sales for both its sequencing and microarray products pushed revenues up for the quarter. It also launched a new version of the HiSeq platform for lower-throughput applications.
Full-text access for registered users only.
Existing users login here.
New to GenomeWeb? Register here quickly for free access.
New to GenomeWeb? Register here quickly for free access.